Citations (100)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Jennifer Kaivers, Esther Schuler, Barbara Hildebrandt, Beate Betz, Christina Rautenberg, Rainer Haas, Guido Kobbe, Norbert Gattermann & Ulrich Germing. (2020) Improving the accuracy of prognostication in chronic myelomonocytic leukemia. Expert Review of Anticancer Therapy 20:8, pages 703-714.
Read now
Read now
Kenji Motohashi, Shin Fujisawa, Noriko Doki, Takeshi Kobayashi, Takehiko Mori, Kensuke Usuki, Masatsugu Tanaka, Shinichiro Fujiwara, Shinichi Kako, Yasuyuki Aoyama, Masahiro Onoda, Shingo Yano, Moritaka Gotoh, Heiwa Kanamori, Satoshi Takahashi & Shinichiro Okamoto. (2018) Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia. Leukemia & Lymphoma 59:6, pages 1332-1337.
Read now
Read now
Guru Subramanian Guru Murthy, Ishwori Dhakal & Paulette Mehta. (2017) Incidence and survival outcomes of chronic myelomonocytic leukemia in the United States. Leukemia & Lymphoma 58:7, pages 1648-1654.
Read now
Read now
Massimo Breccia, Paola Finsinger, Giuseppina Loglisci, Gioia Colafigli, Alessandra Serrao, Adriano Salaroli, Luigi Petrucci & Giuliana Alimena. (2012) Evaluation of prognostic factors for overall survival in patients with chronic myelomonocytic leukemia by different scoring systems: which is the best?. Leukemia & Lymphoma 53:10, pages 2073-2074.
Read now
Read now
SherilynA. Gross, RichardD. Irons, PaulK. Scott, David Galbraith, Xiao
Qin Wang, Yan Chen & Dennis Paustenbach. (2012) A Case-Control Study of Chronic Myelomonocytic Leukemia (CMML) in Shanghai, China: Evaluation of Risk Factors for CMML, With Special Focus on Benzene. Archives of Environmental & Occupational Health 67:4, pages 206-218.
Read now
Read now
Jacqueline S Garcia, Nitin Jain & Lucy A Godley. (2010) An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes. OncoTargets and Therapy 3, pages 1-13.
Read now
Read now
Dhatri Kodali, Hector Mesa, Ajay Rawal, Qing Cao & Pankaj Gupta. (2007) Thrombocytosis in myelodysplastic and myelodysplastic/myeloproliferative syndromes. Leukemia & Lymphoma 48:12, pages 2375-2380.
Read now
Read now
Miloslav Beran, Sijin Wen, Yu Shen, Francesco Onida, Jaroslav Jelinek, Jorge Cortes, Francis Giles & Hagop Kantarjian. (2007) Prognostic factors and risk assessment in chronic myelomonocytic leukemia: Validation study of the M.D. Anderson Prognostic Scoring System. Leukemia & Lymphoma 48:6, pages 1150-1160.
Read now
Read now
Articles from other publishers (92)
Tamara K. Moyo, Jason H. Mendler, Raphael Itzykson, Ashwin Kishtagari, Eric Solary, Adam C. Seegmiller, Aaron T. Gerds, Gregory D. Ayers, Amy E. Dezern, Aziz Nazha, Peter Valent, Arjan A. van de Loosdrecht, Francesco Onida, Lisa Pleyer, Blanca Xicoy Cirici, Raoul Tibes, Klaus Geissler, Rami S. Komrokji, Jing Zhang, Ulrich Germing, David P. Steensma, Daniel H. Wiseman, Michael Pfeilstöecker, Chiara Elena, Nicholas C. P. Cross, Jean-Jacques Kiladjian, Michael Luebbert, Ruben A. Mesa, Guillermo Montalban-Bravo, Guillermo F. Sanz, Uwe Platzbecker, Mrinal M. Patnaik, Eric Padron, Valeria Santini, Pierre Fenaux & Michael R. Savona. (2022) The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes. BMC Cancer 22:1.
Crossref
Crossref
Matthew Mei, Raju Pillai, Soyoung Kim, Noel Estrada-Merly, Michelle Afkhami, Lixin Yang, Zhuo Meng, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Amer Beitinjaneh, Christopher Bredeson, Jean-Yves Cahn, Jan Cerny, Edward Copelan, Corey Cutler, Zachariah DeFilipp, Miguel Angel Diaz Perez, Nosha Farhadfar, César O. Freytes, Shahinaz M. Gadalla, Siddhartha Ganguly, Robert Peter Gale, Usama Gergis, Michael R. Grunwald, Betty K. Hamilton, Shahrukh Hashmi, Gerhard C. Hildebrandt, Hillard M. Lazarus, Mark Litzow, Reinhold Munker, Hemant S. Murthy, Sunita Nathan, Taiga Nishihori, Sagar S. Patel, David Rizzieri, Sachiko Seo, Mithun Vinod Shah, Melhem Solh, Leo F. Verdonck, Ravi Vij, Ronald M. Sobecks, Betul Oran, Bart L. Scott, Wael Saber & Ryotaro Nakamura. (2022) The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis. Haematologica 108:1, pages 150-160.
Crossref
Crossref
Lauren J Pelkey, David M Graham, Michael H Zakem & Michelle M Muza-Moons. (2022) Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report. Cureus.
Crossref
Crossref
Wenmin Han, Feng Zhou, Zheng Wang, Haiying Hua, Wei Qin, Zhuxia Jia, Xiaohui Cai, Meiyu Chen, Jie Liu, Hongying Chao & Xuzhang Lu. (2021) Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance. International Journal of Hematology 115:1, pages 21-32.
Crossref
Crossref
Andrea Kuendgen, Annika Kasprzak & Ulrich Germing. (2021) Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview. Frontiers in Oncology 11.
Crossref
Crossref
Ekaterina Belotserkovskaya & Oleg Demidov. (2021) Mouse Models of CMML. International Journal of Molecular Sciences 22:21, pages 11510.
Crossref
Crossref
Jacqueline S. González, María Agustina Perusini, Ana L. Basquiera, Graciela Alfonso, Dorotea Fantl, Walter Macedo Lima, Elsa Nucifora, Carolina Lazzarino, Viviana Novoa, Marcela Cavalcanti de Andrade Silva, Irene B. Larripa, Vanderson Rocha, Jorge Arbelbide, Elvira D. R. P. Velloso & Carolina B. Belli. (2021) Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patients. Annals of Hematology 100:6, pages 1439-1449.
Crossref
Crossref
J. Kaivers, C. Rautenberg, B. Betz, P. Czyborra, R. Haas, M. Rudelius, M. Lübbert, G. Kobbe & U. Germing. (2021) Diagnostik und Therapie der chronischen myelomonozytären Leukämie im Jahr 2020Diagnosis and treatment of chronic myelomonocytic leukemia in 2020. best practice onkologie 16:1-2, pages 20-28.
Crossref
Crossref
Zheng‐Yu Cheng, Fu‐Shin Chueh, Shu‐Fen Peng, Chia‐Hsin Lin, Chao‐Lin Kuo, Wen‐Wen Huang, Po‐Yuan Chen, Tzong‐Der Way & Jing‐Gung Chung. (2020)
Combinational treatment of 5‐fluorouracil and casticin induces apoptosis in mouse leukemia
WEHI
‐3 cells in vitro
. Environmental Toxicology 35:9, pages 911-921.
Crossref
Crossref
Onyee Chan & Eric Padron. (2020) Moving towards a uniform risk stratification system in CMML - How far are we?. Best Practice & Research Clinical Haematology 33:2, pages 101131.
Crossref
Crossref
Juan Garza, Jane Margret Anderson & Robyn M. Scherber. (2020) Assessing Symptom Burden in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Patients. Hematology/Oncology Clinics of North America 34:2, pages 475-489.
Crossref
Crossref
Megan Melody, Emily Butts, David Menke, Kevin Landolfo, Keith Oken, Taimur Sher & Sharad Khurana. (2020) Use of Tocilizumab in Management of Post-Operative Myelomonocytic Leukemoid Reaction. Leukemia Research Reports 14, pages 100228.
Crossref
Crossref
Yung‐Luen Shih, Hung‐Sheng Shang, Yung‐Liang Chen, Shu‐Ching Hsueh, Hsiao‐Min Chou, Hsu‐Feng Lu, Ming‐Zhe Lee, Hsin‐Tu Hou, Ying‐Ying Chuang, Mei‐Hui Lee, Kuo‐Wei Chen & Jing‐Gung Chung. (2019) Ouabain promotes immune responses in WEHI‐3 cells to generate leukemia mice through enhancing phagocytosis and natural killer cell activities in vivo. Environmental Toxicology 34:5, pages 659-665.
Crossref
Crossref
Raphael Itzykson, Pierre Fenaux, David Bowen, Nicholas C.P. Cross, Jorge Cortes, Theo De Witte, Ulrich Germing, Francesco Onida, Eric Padron, Uwe Platzbecker, Valeria Santini, Guillermo F. Sanz, Eric Solary, Arjan Van de Loosdrecht & Luca Malcovati. (2018) Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults. HemaSphere 2:6, pages e150.
Crossref
Crossref
Sanam Loghavi & Joseph D. Khoury. (2018) Recent Updates on Chronic Myelomonocytic Leukemia. Current Hematologic Malignancy Reports 13:6, pages 446-454.
Crossref
Crossref
Elvira Mora & Guillermo F. Sanz. (2018) Current management of patients with chronic myelomonocytic leukemia. Current Opinion in Oncology 30:6, pages 409-417.
Crossref
Crossref
Sanam Loghavi, Dawen Sui, Peng Wei, Guillermo Garcia-Manero, Sherry Pierce, Mark J. Routbort, Elias J. Jabbour, Naveen Pemmaraju, Rashmi Kanagal-Shamanna, H. Deniz GurShimin Hu, Zhuang ZuoL. Jeffrey Medeiros, Hagop M. Kantarjian & Joseph D. Khoury. (2018) Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories. Blood Advances 2:15, pages 1807-1816.
Crossref
Crossref
Hatice D. Gur, Sanam Loghavi, Guillermo Garcia-Manero, Mark Routbort, Rashmi Kanagal-Shamanna, Andres Quesada, Haitham Khogeer, Sherry Pierce, L. Jeffrey Medeiros, Hagop Kantarjian & Joseph D. Khoury. (2018) Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations. American Journal of Surgical Pathology 42:6, pages 799-806.
Crossref
Crossref
Hidehiro Itonaga, Kazunari Aoki, Jun Aoki, Takayuki Ishikawa, Ken Ishiyama, Naoyuki Uchida, Toru Sakura, Kazuteru Ohashi, Mineo Kurokawa, Yukiyasu Ozawa, Ken-ichi Matsuoka, Yukinori Nakamura, Fumihiko Kimura, Koji Iwato, Yuichiro Nawa, Makoto Hirokawa, Koji Kato, Tatsuo Ichinohe, Yoshiko Atsuta & Yasushi Miyazaki. (2018) Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan. Biology of Blood and Marrow Transplantation 24:4, pages 840-848.
Crossref
Crossref
Matthieu Duchmann, Nolwenn Lucas, Raphael Itzykson & Eric Solary. 2018. Myelodysplastic Syndromes. Myelodysplastic Syndromes
65
79
.
Francesco Onida. (2017) Models of Prognostication in Chronic Myelomonocytic Leukemia. Current Hematologic Malignancy Reports 12:6, pages 513-521.
Crossref
Crossref
Tamara K. Moyo & Michael R. Savona. (2017) Therapy for Chronic Myelomonocytic Leukemia in a New Era. Current Hematologic Malignancy Reports 12:5, pages 468-477.
Crossref
Crossref
Eric Solary & Raphael Itzykson. (2017) How I treat chronic myelomonocytic leukemia. Blood 130:2, pages 126-136.
Crossref
Crossref
Brittany Knick Ragon & Michael R. Savona. (2017) The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms. Clinical Lymphoma Myeloma and Leukemia 17, pages S37-S42.
Crossref
Crossref
Ana Alfonso, Guillermo Montalban-Bravo, Koichi Takahashi, Elias J. Jabbour, Tapan Kadia, Farhad Ravandi, Jorge Cortes, Zeev Estrov, Gautam Borthakur, Naveen Pemmaraju, Marina Konopleva, Carlos Bueso-Ramos, Sherry Pierce, Hagop Kantarjian & Guillermo Garcia-Manero. (2017) Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents. American Journal of Hematology 92:7, pages 599-606.
Crossref
Crossref
Raphael Itzykson, Matthieu Duchmann, Nolwenn Lucas & Eric Solary. (2017) CMML: Clinical and molecular aspects. International Journal of Hematology 105:6, pages 711-719.
Crossref
Crossref
Hien Duong Liu, Kwang Woo Ahn, Zhen-Huan Hu, Mehdi Hamadani, Taiga Nishihori, Baldeep Wirk, Amer Beitinjaneh, David Rizzieri, Michael R. Grunwald, Mitchell Sabloff, Richard F. Olsson, Ashish Bajel, Christopher Bredeson, Andrew Daly, Yoshihiro Inamoto, Navneet Majhail, Ayman Saad, Vikas Gupta, Aaron Gerds, Adriana Malone, Martin Tallman, Ran Reshef, David I. Marks, Edward Copelan, Usama Gergis, Mary Lynn Savoie, Celalettin Ustun, Mark R. Litzow, Jean-Yves Cahn, Tamila Kindwall-Keller, Gorgun Akpek, Bipin N. Savani, Mahmoud Aljurf, Jacob M. Rowe, Peter H. Wiernik, Jack W. Hsu, Jorge Cortes, Matt Kalaycio, Richard Maziarz, Ronald Sobecks, Uday Popat, Edwin Alyea & Wael Saber. (2017) Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia. Biology of Blood and Marrow Transplantation 23:5, pages 767-775.
Crossref
Crossref
M. Monika Belickova, Michaela Dostalova Merkerova, Hana Votavova, Jan Valka, Jitka Vesela, Barbora Pejsova, Hana Hajkova, Jiri Klema, Jaroslav Cermak & Anna Jonasova. (2016) Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms. International Journal of Hematology 104:5, pages 566-573.
Crossref
Crossref
Alexandra M. Harrington, Lindsay A. Schelling, Atousa Ordobazari, Horatiu Olteanu, Paul R. Hosking & Steven H. Kroft. (2016) Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry. American Journal of Clinical Pathology 146:2, pages 170-181.
Crossref
Crossref
C C Mason, J S Khorashad, S K Tantravahi, T W Kelley, M S Zabriskie, D Yan, A D Pomicter, K R Reynolds, A M Eiring, Z Kronenberg, R L Sherman, J W Tyner, B K Dalley, K-H Dao, M Yandell, B J Druker, J Gotlib, T O'Hare & M W Deininger. (2015) Age-related mutations and chronic myelomonocytic leukemia. Leukemia 30:4, pages 906-913.
Crossref
Crossref
Hidehiro Itonaga, Masako Iwanaga, Kazunari Aoki, Jun Aoki, Ken Ishiyama, Takayuki Ishikawa, Toru Sakura, Takahiro Fukuda, Yuho Najima, Toshiaki Yujiri, Takehiko Mori, Mineo Kurokawa, Yuichiro Nawa, Naoyuki Uchida, Yoshihisa Morishita, Hisako Hashimoto, Tetsuya Eto, Makoto Hirokawa, Yasuo Morishima, Tokiko Nagamura-Inoue, Yoshiko Atsuta & Yasushi Miyazaki. (2016) Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study. Leukemia Research 41, pages 48-55.
Crossref
Crossref
Assem A. Elghazaly, Mohmmed U. Manzoor, Mai A. AlMishari & Mamoun H. Ibrahim. (2016) A 27-Year-Old Patient Fulfilling the Diagnostic Criteria of Both CMML and JMML. Case Reports in Oncological Medicine 2016, pages 1-4.
Crossref
Crossref
Xavier Calvo, Meritxell Nomdedeu, Rodrigo Santacruz, Núria Martínez, Dolors Costa, Arturo Pereira, Natalia Estrada, Blanca Xicoy, Jordi Esteve & Benet Nomdedeu. (2015) Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML-specific prognostic scoring system (CPSS) and Mayo prognostic model. A detailed review of prognostic factors in CMML. Leukemia Research 39:11, pages 1146-1153.
Crossref
Crossref
Guilin Tang, Bing Fu, Shimin Hu, Xinyan Lu, Zhenya Tang, Shaoying Li, Kausar Jabbar, Joseph D. Khoury, L. Jeffrey Medeiros & Sa A. Wang. (2015) Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemia. American Journal of Hematology 90:10, pages 882-887.
Crossref
Crossref
Christopher B. Benton, Aziz Nazha, Naveen Pemmaraju & Guillermo Garcia-Manero. (2015) Chronic myelomonocytic leukemia: Forefront of the field in 2015. Critical Reviews in Oncology/Hematology 95:2, pages 222-242.
Crossref
Crossref
David A. Sallman & Eric Padron. (2015) Transformation of the Clinical Management of CMML Patients Through In-Depth Molecular Characterization. Clinical Lymphoma Myeloma and Leukemia 15, pages S50-S55.
Crossref
Crossref
Michael R. Savona, Luca MalcovatiRami KomrokjiRamon V. TiuTariq I. MughalAttilio OraziJean-Jacques KiladjianEric PadronEric SolaryRaoul TibesRaphael ItzyksonMario CazzolaRuben MesaJaroslaw MaciejewskiPierre FenauxGuillermo Garcia-ManeroAaron GerdsGuillermo SanzCharlotte M. NiemeyerFrancisco CervantesUlrich Germing, Nicholas C. P. Cross & Alan F. List. (2015) An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. Blood 125:12, pages 1857-1865.
Crossref
Crossref
Christopher N. Hahn, Parvathy Venugopal, Hamish S. Scott & Devendra K. Hiwase. (2015) Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy. Immunological Reviews 263:1, pages 257-278.
Crossref
Crossref
Jérôme Hadjadj, Marc Michel, Marie-Paule Chauveheid, Bertrand Godeau, Thomas Papo & Karim Sacre. (2014) Immune thrombocytopenia in chronic myelomonocytic leukemia. European Journal of Haematology 93:6, pages 521-526.
Crossref
Crossref
Dorothée Selimoglu-Buet & Eric Solary. (2014) Chronic Myelomonocytic Leukemia Prognostic Classification and Management: Evidence Base and Current Practice. Current Hematologic Malignancy Reports 9:4, pages 301-310.
Crossref
Crossref
. 2014. Morphology of Blood Disorders. Morphology of Blood Disorders
511
552
.
Guilin Tang, Liping Zhang, Bin Fu, Jianhua Hu, Xinyan Lu, Shimin Hu, Ankita Patel, Maitrayee Goswami, Joseph D. Khoury, Guillermo Garcia-Manero, L. Jeffrey Medeiros & Sa A. Wang. (2014) Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution. American Journal of Hematology 89:8, pages 813-818.
Crossref
Crossref
Rena Buckstein, Robert Kerbel, Matthew Cheung, Yuval Shaked, Lisa Chodirker, Christina R. Lee, Martha Lenis, Cindy Davidson, Mary-Anne Cussen, Marciano Reis, Alden Chesney, Liying Zhang, Alexandre Mamedov & Richard A. Wells. (2014) Lenalidomide and metronomic melphalan for CMML and higher risk MDS: A phase 2 clinical study with biomarkers of angiogenesis. Leukemia Research 38:7, pages 756-763.
Crossref
Crossref
Nathalie Cervera, Raphael Itzykson, Emilie Coppin, Thomas Prebet, Anne Murati, Stevan Legall, Norbert Vey, Eric Solary, Daniel Birnbaum & Véronique Gelsi-Boyer. (2014) Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia. American Journal of Hematology 89:6, pages 604-609.
Crossref
Crossref
Sally B. Killick, Chris Carter, Dominic Culligan, Christopher Dalley, Emma Das-Gupta, Mark Drummond, Helen Enright, Gail L. Jones, Jonathan Kell, Juliet Mills, Ghulam Mufti, Jane Parker, Kavita Raj, Alexander Sternberg, Paresh Vyas & David Bowen. (2014) Guidelines for the diagnosis and management of adult myelodysplastic syndromes. British Journal of Haematology 164:4, pages 503-525.
Crossref
Crossref
Raphael Itzkson, Pierre Fenaux & Eric Solary. (2013) Chronic myelomonocytic leukemia: Myelodysplastic or myeloproliferative?. Best Practice & Research Clinical Haematology 26:4, pages 387-400.
Crossref
Crossref
Sameer A. Parikh & Ayalew Tefferi. (2013) Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management. American Journal of Hematology 88:11, pages 967-974.
Crossref
Crossref
Eric Padron & Omar Abdel-Wahab. (2013) Importance of Genetics in the Clinical Management of Chronic Myelomonocytic Leukemia. Journal of Clinical Oncology 31:19, pages 2374-2376.
Crossref
Crossref
Raphaël ItzyksonOlivier KosmiderAline RennevilleVéronique Gelsi-BoyerManja MeggendorferMargot MorabitoCéline BerthonLionel AdèsPierre FenauxOdile Beyne-RauzyNorbert VeyThorsten BraunTorsten HaferlachFrançois DreyfusNicholas C.P. CrossClaude PreudhommeOlivier A. BernardMichaela FontenayWilliam VainchenkerSusanne SchnittgerDaniel BirnbaumNathalie DroinEric Solary. (2013) Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia. Journal of Clinical Oncology 31:19, pages 2428-2436.
Crossref
Crossref
M M Patnaik, E Padron, R R LaBorde, T L Lasho, C M Finke, C A Hanson, J M Hodnefield, R A Knudson, R P Ketterling, A Al-kali, A Pardanani, N A Ali, R S Komroji & A Tefferi. (2013) Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes. Leukemia 27:7, pages 1504-1510.
Crossref
Crossref
Asmita Mishra, Maria Corrales-Yepez, Najla Al Ali, Mohamed Kharfan-Dabaja, Eric Padron, Ling Zhang, Pearlie K. Epling-Burnette, Javier Pinilla-Ibarz, Jeffrey E. Lancet, Alan F. List & Rami S. Komrokji. (2013) Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes. American Journal of Hematology 88:7, pages 566-570.
Crossref
Crossref
Sophie Park, Myriam Labopin, Ibrahim Yakoub‐Agha, Jacques Delaunay, Nathalie Dhedin, Eric Deconinck, Mauricette Michallet, Marie Robin, Thierry De Revel, Marc Bernard, Norbert Vey, Bruno Lioure, Simona Lapusan, Reza Tabrizi, Jean‐Henri Bourhis, Anne Huynh, Yves Beguin, Gérard Socié, François Dreyfus, Pierre Fenaux & Mohamad Mohty. (2013) Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. European Journal of Haematology 90:5, pages 355-364.
Crossref
Crossref
Mike Leach, Mark Drummond & Allyson Doig. 2013. Practical Flow Cytometry in Haematology Diagnosis. Practical Flow Cytometry in Haematology Diagnosis
152
172
.
Gopi K Prithviraj, Blessy M Mathew, Rami K Komrokji, Alan F List & Eric Padron. (2013) Chronic myelomonocytic leukemia: a review of the molecular biology, prognostic models and treatment. International Journal of Hematologic Oncology 2:2, pages 151-162.
Crossref
Crossref
Mrinal M. Patnaik, Terra L. Lasho, Christy M. Finke, Curtis A. Hanson, Janice M. Hodnefield, Ryan A. Knudson, Rhett P. Ketterling, Animesh Pardanani & Ayalew Tefferi. (2013)
Spliceosome mutations involving
SRSF2
,
SF3B1
, and
U2AF35
in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance
. American Journal of Hematology 88:3, pages 201-206.
Crossref
Crossref
Sonja Burgstaller. (2013) Chronic myelomonocytic leukaemia: diagnosis and therapeutic implications. memo - Magazine of European Medical Oncology 6:1, pages 32-36.
Crossref
Crossref
Sung-Nam LimJe-Hwan LeeJung-Hee LeeDae-Young KimSung Doo KimYoung-A KangYoung-Shin LeeKyoo-Hyung Lee. (2013) Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms. Blood Research 48:3, pages 178.
Crossref
Crossref
Betty Lamothe, YunJu Lai, Lana Hur, Natalia Martin Orozco, Jing Wang, Alejandro D. Campos, Min Xie, Michael D. Schneider, Cynthia R. Lockworth, Jared Jakacky, Diep Tran, Michael Ho, Sity Dawud, Chen Dong, Hui-Kuan Lin, Peter Hu, Zeev Estrov, Carlos E. Bueso-Ramos & Bryant G. Darnay. (2012) Deletion of TAK1 in the Myeloid Lineage Results in the Spontaneous Development of Myelomonocytic Leukemia in Mice. PLoS ONE 7:12, pages e51228.
Crossref
Crossref
Ulrich Germing & Andrea Kündgen. (2012) Prognostic scoring systems in MDS. Leukemia Research 36:12, pages 1463-1469.
Crossref
Crossref
Manja MeggendorferAndreas RollerTorsten HaferlachChristiane EderFrank DickerVera GrossmannAlexander KohlmannTamara AlpermannKenichi YoshidaSeishi OgawaH. Phillip Koeffler, Wolfgang KernClaudia HaferlachSusanne Schnittger. (2012) SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood 120:15, pages 3080-3088.
Crossref
Crossref
Gemma Osca-Gelis, Montserrat Puig-Vives, Marc Saez, David Gallardo, Francesc Solé & Rafael Marcos-Gragera. (2012) Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): A population-based study, 1993–2007. Leukemia Research 36:10, pages 1262-1266.
Crossref
Crossref
Michael Thorpe, Ana Montalvão, Francesca Pierdomenico, Filipa Moita & António Almeida. (2012) Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: A case series and literature review. Leukemia Research 36:8, pages 1071-1073.
Crossref
Crossref
Sameer A. Parikh & Ayalew Tefferi*. (2012) Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management. American Journal of Hematology 87:6, pages 610-619.
Crossref
Crossref
Rami S. Komrokji, Maria Corrales‐Yepez, Najla Al Ali, Mohammad Kharfan‐Dabaja, Eric Padron, Teresa Fields, Jeffrey E. Lancet & Alan F. List. (2011) Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome. Cancer 118:10, pages 2659-2664.
Crossref
Crossref
Rahel A. Mathew, John M. Bennett, Jane Jijun Liu, Rami S. Komrokji, Jeffrey E. Lancet, Mojdeh Naghashpour, Jane L. Messina, Alan F. List, Lynn C. Moscinski & Ling Zhang. (2012) Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature. Leukemia Research 36:1, pages 72-80.
Crossref
Crossref
Elizabeth Hyjek & James W. Vardiman. (2011) Myelodysplastic/myeloproliferative neoplasms. Seminars in Diagnostic Pathology 28:4, pages 283-297.
Crossref
Crossref
Rubens Costa, Haifaa Abdulhaq, Bushra Haq, Richard K. Shadduck, Joan Latsko, Mazen Zenati, Folefac D. Atem, James M. Rossetti, Entezam A. Sahovic & John Lister. (2010) Activity of azacitidine in chronic myelomonocytic leukemia. Cancer 117:12, pages 2690-2696.
Crossref
Crossref
Zeba N. Singh, Ginell R. Post, Elias Kiwan & Anne-Marie Maddox. (2011) Cytopenia, Dysplasia, and Monocytosis: A Precursor To Chronic Myelomonocytic Leukemia or a Distinct Subgroup? Case Reports and Review of Literature. Clinical Lymphoma Myeloma and Leukemia 11:3, pages 293-297.
Crossref
Crossref
Ulrike Bacher, Torsten Haferlach, Susanne Schnittger, Hans Kreipe & Nicolaus Kröger. (2011) Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia. British Journal of Haematology 153:2, pages 149-167.
Crossref
Crossref
M Czader & A Orazi. 2011. Blood and Bone Marrow Pathology. Blood and Bone Marrow Pathology
391
406
.
Alexander KohlmannVera GrossmannHans-Ulrich KleinSonja SchindelaTamara WeissBeray KazakFrank DickerSusanne SchnittgerMartin DugasWolfgang KernClaudia HaferlachTorsten Haferlach. (2010)
Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in
TET2
,
CBL
,
RAS
, and
RUNX1
. Journal of Clinical Oncology 28:24, pages 3858-3865.
Crossref
Crossref
Bobin Chen, Yan Ma, Xiaoping Xu, Xiaoqin Wang, Wenjiao Qin, Meirong Ji & Guowei Lin. (2010) Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China. Leukemia Research 34:4, pages 458-462.
Crossref
Crossref
Rami S. Komrokji, Ling Zhang & John M. Bennett. (2010) Myelodysplastic Syndromes Classification and Risk Stratification. Hematology/Oncology Clinics of North America 24:2, pages 443-457.
Crossref
Crossref
Lisa Pleyer, Daniel Neureiter, Victoria Faber & Richard Greil. 2010. Chronic Myeloid Neoplasias and Clonal Overlap Syndromes. Chronic Myeloid Neoplasias and Clonal Overlap Syndromes
223
233
.
Qian Sun, Chi-Chiu So, Sze-Fai Yip, Thomas S.K. Wan, Shiu-Kwan Ma & L.C. Chan. (2008) Functional alterations of Lin−CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia. Leukemia Research 32:9, pages 1374-1381.
Crossref
Crossref
P D Emanuel. (2008) Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia. Leukemia 22:7, pages 1335-1342.
Crossref
Crossref
A Orazi & U Germing. (2008) The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Leukemia 22:7, pages 1308-1319.
Crossref
Crossref
P.W. Wijermans, B. Rüter, M.R. Baer, J.L. Slack, H.I. Saba & M. Lübbert. (2008) Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML). Leukemia Research 32:4, pages 587-591.
Crossref
Crossref
Francesco Onida & Miloslav Beran. (2008) Diagnosis and management of chronic myelomonocytic leukemia. Current Hematologic Malignancy Reports 3:1, pages 31-36.
Crossref
Crossref
Nigel E Drury, Ayyaz Ali, Shafi Mussa, Stephen T Webb, Kanchan P Rege & John Wallwork. (2007) Acute leukaemoid reaction following cardiac surgery. Journal of Cardiothoracic Surgery 2:1.
Crossref
Crossref
U Platzbecker, B Mohr, M von Bonin, M Binder, J Schetelig, G Ehninger & M Bornhäuser. (2007) Lenalidomide as induction therapy before allogeneic stem cell transplantation in a patient with proliferative CMML-2 and del(5q) not involving the EGR1 locus. Leukemia 21:11, pages 2384-2385.
Crossref
Crossref
Ethan A. Natelson. (2007) Benzene‐induced acute myeloid leukemia: A clinician's perspective. American Journal of Hematology 82:9, pages 826-830.
Crossref
Crossref
Pierre FenauxAzra RazaGhulam J. MuftiCarlo AulUlrich GermingHagop KantarjianLarry CripeRené Kerstens, Peter De Porre & Razelle Kurzrock. (2007) A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome. Blood 109:10, pages 4158-4163.
Crossref
Crossref
Torsten Haferlach, Ulrike Bacher, Wolfgang Kern, Susanne Schnittger, Winfried Gassmann & Claudia Haferlach. (2007) A comprehensive approach to the diagnosis of MDS after triage by morphology towards cytogenetics and other techniques. Cancer Treatment Reviews 33, pages S31-S41.
Crossref
Crossref
Mark R. Litzow. (2006) Myelodysplastic/Myeloproliferative Disorder Overlap Syndrome: How Should it be Approached?. Clinical Leukemia 1:2, pages 95-100.
Crossref
Crossref
Sa A. Wang, Naomi Galili, Jan Cerny, Eric Sechman, Su Sin Chen, Jerome Loew, Qin Liu, Fadare Oluwole, Robert Hasserjian, Dan Jones, Huma Qawi, Bruce Woda & Azra Raza. (2006) Chronic Myelomonocytic Leukemia Evolving From Preexisting Myelodysplasia Shares Many Features With De Novo Disease. American Journal of Clinical Pathology 126:5, pages 789-797.
Crossref
Crossref
Michelle A. ElliottMDMD. (2006) Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined. Best Practice & Research Clinical Haematology 19:3, pages 571-593.
Crossref
Crossref
Rosangela Invernizzi, Erica Travaglino, Chiara Benatti, Luca Malcovati, Matteo Della Porta, Mario Cazzola & Edoardo Ascari. (2006) Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia. European Journal of Haematology 76:6, pages 494-501.
Crossref
Crossref
M A Elliott, A Tefferi, W J Hogan, L Letendre, D A Gastineau, S M Ansell, A Dispenzieri, M A Gertz, S R Hayman, D J Inwards, M Q Lacy, I N Micallef, L F Porrata & M R Litzow. (2006) Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia. Bone Marrow Transplantation 37:11, pages 1003-1008.
Crossref
Crossref
Ayalew Tefferi, Michelle A. Elliott & Animesh Pardanani. (2006) Atypical Myeloproliferative Disorders: Diagnosis and Management. Mayo Clinic Proceedings 81:4, pages 553-563.
Crossref
Crossref
U Germing, B Hildebrandt, M Pfeilstöcker, T Nösslinger, P Valent, C Fonatsch, M Lübbert, D Haase, C Steidl, O Krieger, R Stauder, A A N Giagounidis, C Strupp, A Kündgen, T Mueller, R Haas, N Gattermann & C Aul. (2005) Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). Leukemia 19:12, pages 2223-2231.
Crossref
Crossref
Kazuko Uno, Yoshiki Suginoshita, Kazuhiro Kakimi, Fuminori Moriyasu, Mayumi Hirosaki, Taro Shirakawa & Tsunataro Kishida. (2005) Impairment of IFN-α production capacity in patients with hepatitis C virus and the risk of the development of hepatocellular carcinoma. World Journal of Gastroenterology 11:46, pages 7330.
Crossref
Crossref